| Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients MN Theodoraki, SS Yerneni, TK Hoffmann, WE Gooding, TL Whiteside Clinical cancer research 24 (4), 896-905, 2018 | 573 | 2018 |
| Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer S Ludwig, T Floros, MN Theodoraki, CS Hong, EK Jackson, S Lang, ... Clinical Cancer Research 23 (16), 4843-4854, 2017 | 308 | 2017 |
| Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT MN Theodoraki, S Yerneni, WE Gooding, J Ohr, DA Clump, JE Bauman, ... Oncoimmunology 8 (7), e1593805, 2019 | 130 | 2019 |
| Separation of plasma-derived exosomes into CD3(+) and CD3(−) fractions allows for association of immune cell and tumour cell markers with disease activity in … MN Theodoraki, TK Hoffmann, TL Whiteside Clinical & Experimental Immunology 192 (3), 271-283, 2018 | 89 | 2018 |
| Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence MN Theodoraki, TK Hoffmann, EK Jackson, TL Whiteside Clinical & Experimental Immunology 194 (1), 67-78, 2018 | 85 | 2018 |
| Isolation and analysis of tumor‐derived exosomes N Ludwig, CS Hong, S Ludwig, JH Azambuja, P Sharma, MN Theodoraki, ... Current protocols in immunology 127 (1), e91, 2019 | 77 | 2019 |
| Molecular and functional profiles of exosomes from HPV (+) and HPV (−) head and neck cancer cell lines S Ludwig, P Sharma, MN Theodoraki, M Pietrowska, SS Yerneni, S Lang, ... Frontiers in oncology 8, 445, 2018 | 65 | 2018 |
| Evaluation of exosome proteins by on‐bead flow cytometry MN Theodoraki, CS Hong, VS Donnenberg, AD Donnenberg, ... Cytometry Part A 99 (4), 372-381, 2021 | 63 | 2021 |
| The emerging role of exosomes in diagnosis, prognosis, and therapy in head and neck cancer L Hofmann, S Ludwig, JM Vahl, C Brunner, TK Hoffmann, MN Theodoraki International journal of molecular sciences 21 (11), 4072, 2020 | 63 | 2020 |
| NF-κB and its role in checkpoint control AC Betzler, MN Theodoraki, PJ Schuler, J Döscher, S Laban, ... International Journal of Molecular Sciences 21 (11), 3949, 2020 | 57 | 2020 |
| CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients’ plasma as potential noninvasive biomarkers of disease activity MN Theodoraki, A Matsumoto, I Beccard, TK Hoffmann, TL Whiteside Oncoimmunology 9 (1), 1747732, 2020 | 52 | 2020 |
| Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer MN Theodoraki, K Lorenz, R Lotfi, D Fuerst, C Tsamadou, S Jaekle, ... Photodiagnosis and photodynamic therapy 19, 194-201, 2017 | 48 | 2017 |
| Plasma-derived exosomes reverse epithelial-to-mesenchymal transition after photodynamic therapy of patients with head and neck cancer MN Theodoraki, SS Yerneni, C Brunner, J Theodorakis, TK Hoffmann, ... Oncoscience 5 (3-4), 75, 2018 | 45 | 2018 |
| Mental distress and effort to engage an image-guided navigation system in the surgical training of endoscopic sinus surgery: a prospective, randomised clinical trial MN Theodoraki, GJ Ledderose, S Becker, A Leunig, S Arpe, M Luz, ... European Archives of Oto-Rhino-Laryngology 272, 905-913, 2015 | 41 | 2015 |
| Immune suppressive effects of plasma-derived exosome populations in head and neck cancer IJ Beccard, L Hofmann, JC Schroeder, S Ludwig, S Laban, C Brunner, ... Cancers 12 (7), 1997, 2020 | 36 | 2020 |
| Helicase-driven activation of NFκB-COX2 pathway mediates the immunosuppressive component of dsRNA-driven inflammation in the human tumor microenvironment MN Theodoraki, S Yerneni, SN Sarkar, B Orr, R Muthuswamy, J Voyten, ... Cancer research 78 (15), 4292-4302, 2018 | 35 | 2018 |
| Changes in circulating exosome molecular profiles following surgery/(chemo) radiotherapy: early detection of response in head and neck cancer patients MN Theodoraki, S Laban, EK Jackson, R Lotfi, PJ Schuler, C Brunner, ... British journal of cancer 125 (12), 1677-1686, 2021 | 34 | 2021 |
| Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma SS Jeske, PJ Schuler, J Doescher, MN Theodoraki, S Laban, C Brunner, ... Immunity & Ageing 17, 1-11, 2020 | 32 | 2020 |
| MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy S Laban, G Giebel, N Klümper, A Schröck, J Doescher, G Spagnoli, ... Oncotarget 8 (9), 14719, 2017 | 29 | 2017 |
| Circulating exosomes inhibit B cell proliferation and activity JC Schroeder, L Puntigam, L Hofmann, SS Jeske, IJ Beccard, J Doescher, ... Cancers 12 (8), 2110, 2020 | 26 | 2020 |
